Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.12
Bid: 0.11
Ask: 0.13
Change: 0.005 (4.35%)
Spread: 0.02 (18.182%)
Open: 0.115
High: 0.125
Low: 0.115
Prev. Close: 0.115
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of options

15 Jun 2015 07:00

RNS Number : 1071Q
Deltex Medical Group PLC
15 June 2015
 

Deltex Medical Group plc

 

Grant of options

 

15 June 2015 - Deltex Medical Group plc (the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that the Board has approved the issue of share options to Ewan Phillips, Chief Executive.

 

Employee Share Option Scheme

 

The Board has approved the issue of share options to Ewan Phillips, Chief Executive, under the Company's 2011 Executive Share Option Scheme ("ESOS") as follows:

 

Name

Number

Exercise

Price £

Exercise period

Total Number of ESOS options held*

Ewan Phillips

1,250,000

0.11

2018 - 2025

4,550,000

 

\* The total number of ESOS options held includes those awarded under the Company's 2001 Executive Share Option Scheme

 

These options are subject to certain performance conditions being achieved. The Company did not make its normal ESOS awards in either 2013 or 2014. The Company currently intends to make a further ESOS award between publication of its interim results and its year end of 31 December 2015. The exercise price has been set at 11p per share, being the price of the placing and open offer completed in June 2014. This represents a premium of 69.2% over the current share price.

 

Additional interests

 

Mr Phillips has a beneficial interest in 2,645,189 ordinary shares in the Company representing 1.23 per cent of the issued ordinary share capital of the Company.

 

Mr Phillips also holds a total of 2,337,211 options under the Company's Enterprise Management Incentive ("EMI") scheme. Awards under this scheme relate to sacrifices of bonus and salary cash entitlements.

 

All shares and options relate to ordinary 1p shares.

 

For further information, please contact:-

 

Deltex Medical Group plc

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman

Ewan Phillips, Chief Executive

Barry Curtis, Company Secretary

Nominated Adviser & Broker

Arden Partners plc

020 7614 5900

Chris Hardie

 

Joint Broker

Zeus Capital Limited

Phil Walker

Dominic Wilson

 

 

 

020 7533 7727

 

Financial Public Relations

Newgate

020 7653 9850

Tim Thompson

Robyn McConnachie

Ed Treadwell

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLFFVFRFISLIE
Date   Source Headline
2nd Mar 20073:56 pmRNSDeltex SupraQ Demo Invite
28th Feb 20075:20 pmRNSTotal Voting Rights
27th Feb 20077:34 amRNSReimbursement Coverage in USA
22nd Feb 20071:10 pmRNSHolding(s) in Company
19th Feb 20079:30 amRNSSupraQ Progress
16th Feb 20077:00 amRNSSupraQ development & Placing
25th Jan 200712:33 pmRNSGerman Contract Win
22nd Jan 20073:15 pmRNSDirector/PDMR Shareholding
18th Jan 20077:52 amRNSContract Award
16th Jan 20077:01 amRNSTrading Statement
15th Jan 20079:31 amRNSFirst Maternity Unit Sales
4th Jan 20077:00 amRNSPublication of clinical study
3rd Jan 20077:00 amRNSHigh Risk Surgery Study
20th Dec 20068:37 amRNSTotal Voting Rights
19th Dec 20067:02 amRNSHospital Stay Length Results
18th Dec 20066:07 pmRNSHospital Stay Length Results
23rd Nov 20063:45 pmRNSDirector/PDMR Shareholding
23rd Nov 20063:05 pmRNSDirector/PDMR Shareholding
4th Oct 20067:01 amRNSPublication of clinical trial
28th Sep 200611:30 amRNSInterim Results
26th Sep 200610:58 amRNSSpinal Surgery Trial Results
26th Sep 20069:36 amRNSPositive Meta-analysis Result
18th Sep 20064:08 pmRNSHolding(s) in Company
18th Sep 200610:06 amRNSESCP Conference
18th Sep 20067:01 amRNSNew CardioQ. trial
31st Aug 20067:01 amRNSClinical Trial Results
25th Jul 20067:00 amRNSTrading Statement
15th Jun 20067:46 amRNSCardioQ Upgrade
25th May 20064:00 pmRNSDirector/PDMR Shareholding
22nd May 20061:18 pmRNSDirector/PDMR Shareholding
19th May 20064:26 pmRNSDirector/PDMR Shareholding
19th May 200612:49 pmRNSHolding(s) in Company
18th May 20066:14 pmRNSResult of Clinical Audit
3rd May 200612:33 pmRNSAGM/Trading Update
28th Mar 20063:18 pmRNSDirector/PDMR Shareholding
21st Mar 20067:02 amRNSFinal Results
16th Mar 20067:01 amRNSProduct Update
14th Feb 20067:00 amRNSNICE Review
7th Feb 20067:01 amRNSAcquisition of TECO
18th Jan 20069:44 amRNSDirector/PDMR Shareholding
16th Jan 20064:36 pmRNSDirector Shareholding
12th Jan 20067:00 amRNSTrading Update
10th Jan 20063:52 pmRNSHolding(s) in Company
23rd Dec 200512:04 pmRNSDirector/PDMR Shareholding
27th Oct 20053:33 pmRNSDirector/PDMR Shareholding
21st Oct 20057:00 amRNSDirector/PDMR Shareholding
20th Oct 20052:06 pmRNSDirector/PDMR Shareholding
29th Sep 20057:04 amRNSInterim Results
28th Sep 200511:33 amRNSNotice of Results
23rd Sep 20054:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.